Resumen del estudio
Overall, this study highlights the therapeutic promise of glycowithanolides in managing anxiety disorders and offers a mechanistic basis for future SUPPLEMENTARY INFORMATION: The online version contains supplementary material © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2026. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms
Detalles bibliográficos
- Autores: Rahaman M, Ghosh S
- Publicado en: In silico pharmacology
- Fecha: 2026
- PMID: 42130673
- DOI: 10.1007/s40203-026-00640-5
📖 Leer el estudio completo en PubMed →
Esta evidencia se ha indexado automáticamente desde la base de datos PubMed (NCBI/NLM, US National Institutes of Health). El resumen mostrado es propiedad intelectual de sus autores y editorial.
